Invetx
Colin Giles is the Chief Development Officer at Invetx. He's passionate about bringing Invetx’s portfolio of innovative veterinary biotherapeutics through the regulatory process to be available to practicing veterinarians and their patients. Colin has 35 years of experience in the management of R&D in the Animal Health Industry including many years in senior leadership positions; focused on bringing innovative veterinary medicines to the marketplace.
Colin holds a BVetMed and a Ph.D. from Royal Veterinary College, University of London, UK.
This person is not in any offices
Invetx
At Invetx, they bring the best of biopharma to animal health. Their network includes experts in both animal and human health, veterinary scientists, and clinicians. Their vision is of a global animal health industry that fully leverages biopharma technologies to deliver dramatically improved health outcomes for pets and farm animal populations.